logo

CRDF

Cardiff Oncology·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.76 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy CRDF Now?
  • Based on a composite score of 4.76/10, we rate CRDF as a Netural. Our analysis breaks down into 4.46/10 for Fundamentals, 4.83/10 for Technicals, and 4.87/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is CRDF fundamentally strong?
What is the current technical signals for CRDF?
What is the market sentiment for CRDF?